Tectonic Therapeutic, Inc. (TECX)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$30.75+2.77%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · TECX
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Expenses & Income | |||||||||
| R&D Expenses | 72.2 | 63.5 | 41.4 | 37.0 | 72.2 | 83.1 | 87.2 | 55.0 | 35.1 |
| Operating Income | (94.9) | (84.0) | (58.0) | (44.6) | (105.4) | (118.8) | (120.2) | (75.8) | (46.2) |
| Earnings from Continuing Operations | |||||||||
| Interest Expense | — | 0.1 | 0.1 | — | — | — | — | — | — |
| Interest & Investment Income | 9.7 | 11.3 | 4.3 | 0.6 | — | — | 0.7 | 2.9 | 1.7 |
| Other Non-Operating Income / Expenses | 9.5 | 11.1 | 0.0 | 1.8 | (0.5) | (0.3) | 0.5 | 2.8 | (0.1) |
| Asset Writedown | — | — | — | 0.0 | 0.0 | — | — | — | — |
| EBT, Incl. Unusual Items | — | (72.9) | — | — | — | — | — | — | — |
| Income Tax Expense | — | 1.2 | — | 0.0 | 0.0 | — | — | — | — |
| Net Income | |||||||||
| Minority Interest | — | — | — | (12.5) | 105.9 | — | — | — | — |
| Net Income | (74,162.6) | (74.2) | (58.0) | (42,823.0) | (105.9) | (119.1) | (119.7) | (73.0) | (46.4) |
| Per Share | |||||||||
| Basic EPS | (3,910.70) | (4.05) | (6.83) | (33.76) | (2.42) | (2.78) | — | — | — |
| Diluted EPS | (3,910.70) | (4.05) | (6.83) | (33.76) | (2.42) | (2.78) | — | — | — |
| Basic Weighted Avg Shares | 19.0 | 18.3 | 8.5 | 1.3 | 43.7 | 0.0 | — | — | — |
| Diluted Weighted Avg Shares | 19.0 | 18.3 | 8.5 | 1.3 | 43.7 | 0.0 | — | — | — |
| Supplemental | |||||||||
| EBITDA | — | (82.7) | (56.4) | (43.2) | (104.0) | (117.4) | (119.0) | (75.0) | (45.9) |
| EBIT | (94.9) | (84.0) | (58.0) | (44.6) | (105.4) | (118.8) | (120.2) | (75.8) | (46.2) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.